New drug aims to boost walking ability in adults with muscle-weakening disease
Symptom relief
Ongoing
This study tests an experimental drug called NMD670 in 54 adults with type 3 spinal muscular atrophy, a condition that causes muscle weakness. Participants take the drug or a placebo for a period, then switch, to see if the drug improves walking distance and muscle strength. The …
Phase: PHASE2 • Sponsor: NMD Pharma A/S • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC